IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA panel endorses HIV prevention drug

A Food and Drug Administration advisory panel this week recommended the approval of a drug targeting “high-risk” people to prevent them from getting infected with HIV. Dr. Roy Gulick, chief of infectious diseases at New York Presbyterian, explains the drug's uses.